Long-Term Comparison of 7 SARS-CoV-2 Antibody Assays in the North Zealand Covid-19 Cohort

BACKGROUND: Throughout the coronavirus disease 2019 (Covid-19) pandemic numerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody assays have been approved through Emergency Use Authorization and require further evaluation of sensitivity and specificity in clinical laboratory se...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiwe, Elias F, Carlsson, Elin R, Rasmussen, Christina L, Rasmussen, Pernille, Ougaard, Robert, Hansen, Steen I, Schiøler, Thomas, Kristiansen, Søren, Hansen, Young B, Hillig, Thore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903407/
https://www.ncbi.nlm.nih.gov/pubmed/35134936
http://dx.doi.org/10.1093/jalm/jfab173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903407/
https://www.ncbi.nlm.nih.gov/pubmed/35134936
http://dx.doi.org/10.1093/jalm/jfab173

Ejemplares similares